February 23rd, 2011
Bills Would End DTC Tax Break & Allow Importation
Call it congressional deja vu. Last week, a pair of bills that previously went nowhere were again introduced and both take aim at brand-name drugmakers. The first, called the Say No to Drug Ads Act, would eliminate tax breaks for direct-to-consumer advertising and was introduced by Jerry Nadler, a Democratic Congressman from New York who failed to enlist any co-sponsors.
The rationale for his repeat effort is that DTC ads allow drugmakers to “keep prices artificially high, steering consumers - and physicians - away from generics.It’s bad enough that TV drug ads mislead consumers and tout benefits of high-priced drugs without properly conveying the risks, but the drug companies don’t need extra subsidies to do so,” he says in a statement.
Meanwhile, the other bill, which is called the Pharmaceutical Market Access and Drug Safety Act, would allow licensed pharmacies and wholesalers to import FDA-approved meds from countries with safety standards equivalent to what is found in the US and Canada.
Read more: Read more: http://www.pharmalot.com/2011/02/bills-would-end-dtc-tax-breaks-allow-importation/